The Department of Health and Human Services announced on November 20 that the Centers for Medicare and Medicaid Services has awarded $47 million to 15 organizations under the MAHA ELEVATE model, a test of functional and lifestyle medicine for people in Original Medicare. The awards are the model’s first cohort.
The recipients, which include Duke University, Johns Hopkins University, Massachusetts General Hospital, the Icahn School of Medicine at Mount Sinai, UCLA and Vanderbilt University Medical Center, will test interventions for heart failure, dementia, diabetes, obesity and hypertension. Every selected proposal includes a nutrition or physical activity component. Projects range from dietitian coaching with home blood pressure monitoring and remote clinician alerts, to produce prescriptions, fall prevention education for people with cognitive impairment, and virtual behavioural programmes covering nutrition, activity, sleep and stress.
The CMS Innovation Center received nearly 450 applications and chose the 15 through a merit review weighing evaluability, policy compliance, clinical soundness and cost saving potential. CMS says about 45 percent of Medicare beneficiaries had four or more chronic conditions in 2022, and that beneficiaries with chronic conditions accounted for nearly 90 percent of total health care expenditures. Under the model’s design, up to 30 recipients across two cohorts will receive approximately $3.3 million each over a three year period, and CMS plans a further funding opportunity for up to 15 additional awards in 2027.
The significance is evidentiary rather than immediate. These services sit outside what Original Medicare covers, so the model is designed to build a United States evidence base on cost and quality before any coverage decision. For providers and digital health companies selling nutrition and coaching programmes, a positive evaluation would open a reimbursement path that does not currently exist.